Market revenue in 2023 | USD 95.0 million |
Market revenue in 2030 | USD 174.8 million |
Growth rate | 9.1% (CAGR from 2023 to 2030) |
Largest segment | Human donor tissue-derived products |
Fastest growing segment | Human Donor Tissue-Derived Products |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Human Donor Tissue-Derived Products, Acellular Animal-derived Products |
Key market players worldwide | 3M Co, Organogenesis Holdings Inc Class A, Integra Lifesciences Holdings Corp, Smith & Nephew PLC, MiMedx Group Inc, Essity AB Class B, Stryker Corp, Vericel Corp, Mallinckrodt PLC Ordinary Shares - New, Tissue Regenix |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biological skin substitutes market will help companies and investors design strategic landscapes.
Human donor tissue-derived products was the largest segment with a revenue share of 67.05% in 2023. Horizon Databook has segmented the Asia Pacific biological skin substitutes market based on human donor tissue-derived products, acellular animal-derived products covering the revenue growth of each sub-segment from 2018 to 2030.
Asia Pacific medical device outsourcing market held the largest share 41.3% in 2023 and is expected to witness lucrative growth owing to the availability of several opportunities in this region, especially in Japan, China, and India. Some of the factors such as improved regulatory framework, high-cost savings, a large number of clinical trials conducted in the region and increase in the number of medical device companies venturing into the region are expected to drive the Asia Pacific market.
Furthermore, availability of a skilled workforce within the region at a lower cost compared to the U.S. is another factor that is anticipated to propel the market growth. Furthermore, outsourcing of certain services such as business process outsourcing, knowledge process outsourcing, clinical data management, regulatory writing, pharmacovigilance, and medical coding has witnessed an increase in the past 5 years. These services are majorly outsourced to countries such as the Philippines, India, Korea, Japan, Malaysia, Singapore, and Australia.
However, Japan is the largest market in the Asia Pacific region, majorly due to high healthcare expenditure and rapid introduction of advanced medical devices in the market. The increase in the rate of outsourcing consulting services from developed economies to emerging nations such as India and China is also expected to propel market growth over the forecast period.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific biological skin substitutes market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific biological skin substitutes market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account